The effects of sleep disturbances on patients receiving methadone treatment for opioid use disorder: cortical thickness evidence - Top-Institutions - MDSpire

The effects of sleep disturbances on patients receiving methadone treatment for opioid use disorder: cortical thickness evidence

  • By

  • Feng Cui

  • Yan Chang

  • Xin-Wei Ma

  • Tang-Fen Wang

  • Xin Zhang

  • Tao Hu

  • Qing-Qian Guo

  • Xiao-Yu Feng

  • Xu Guo

  • Tian-Xiao Shen

  • Xiao-Dong Yang

  • Jian Zheng

  • Ke-Jia Hu

  • Jian-Bing Zhu

  • March 25, 2026

  • 0 min

Share

Top Institutions in Psychiatry

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Addiction Medicine
    • Neuroimaging
    • Sleep Medicine

  • #2

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Addiction Psychiatry
    • Neuroimaging
    • Sleep Research

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Addiction Medicine
    • Neuroimaging
    • Sleep Disorders

  • #4

    University of Pennsylvania Perelman School of Medicine
    University of Pennsylvania Perelman School of Medicine

    Philadelphia, PA

    Key Differentiators

    • Addiction Psychiatry
    • Neuroimaging
    • Sleep Medicine

  • #5

    Columbia University Irving Medical Center
    Columbia University Irving Medical Center

    New York, NY

    Key Differentiators

    • Addiction Medicine
    • Neuroimaging
    • Sleep Research

Original Source(s)

The effects of sleep disturbances on patients receiving methadone treatment for opioid use disorder: cortical thickness evidence

  • by Feng Cui, Yan Chang, Xin-Wei Ma, Tang-Fen Wang, Xin Zhang, Tao Hu, Qing-Qian Guo, Xiao-Yu Feng, Xu Guo, Tian-Xiao Shen, Xiao-Dong Yang, Jian Zheng, Ke-Jia Hu, Jian-Bing Zhu

  • March 25, 2026

Related Content

U.S. overdose deaths fell again in 2025, but some worry about policy and drug supply changes

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

Top 10 States With Rising Demand for Physicians

These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.